Our Team

Leadership

Mina Ahmadi, Ph.D.

Founder & CEO

Dr. Mina Ahmadi brings over eight years of experience in cell therapy and cancer biology to NeXell Therapeutics, with extensive expertise in cell therapy innovation and process development. Dr. Ahmadi completed her Ph.D. at McGill University followed by a post-doctoral fellowship at the University of Toronto.

Prior to founding NeXell, Dr. Ahmadi served as a lead of the Cell Therapy Innovation team at Thermo Fisher Scientific, where she developed a novel, automated 24-hour CAR-T manufacturing process in 2023. This breakthrough enabled the shortest known CAR-T production timeline while generating highly potent CAR-T cells capable of efficiently eliminating cancer cells. Prior to that, she was a Lead Scientist at the Centre for Commercialized Regenerative Medicine (CCRM) where she led stem cell gene editing and differentiation platform.

Dr. Ahmadi's groundbreaking work in cell therapy manufacturing has attracted significant interest and is currently being evaluated in clinical settings. Her innovation aims to improve patient access, enable efficient scalability, and enhance therapeutic efficacy by minimizing T-cell exhaustion caused by extended ex vivo expansion.

Prior Key Achievements

Awards & Recognition

Recognized with the Innovation Award by Thermo Fisher Scientific in February 2025, as part of the company's core 4i Values: Integrity, Intensity, Innovation, and Involvement.

Awarded Innovation Grants by Thermo Fisher Scientific in March 2024 and September 2024 as part of their highly competitive global "Best Idea" competition.

24-Hour CAR-T Manufacturing Process

While serving as a lead in the Cell Therapy Innovation team at Thermo Fisher Scientific, developed a 24-hour CAR-T manufacturing process aimed at reducing costs, accelerating patient access, and improving therapeutic efficacy. This work is being evaluated in clinical settings.

View Publication

"innovation in the CAR T space is much needed. New approaches to easing the patient experience and making more potent CAR therapies accessible to more patients is the goal. Thanks to the author s and innovators for continuing to push the envelope and increase understanding!"

Karen Walker

CTO, Kyverna Therapeutics

View Endorsement

Webinars

Key Publications

Intellectual Property Portfolio

Developed a robust intellectual property portfolio with 5 provisional patents covering our proprietary auto-switch technology and multi-level control systems for engineered immune cells.

Full Team Announcement Coming Soon

We're assembling a world-class team of scientists, researchers, and industry experts who share our vision of revolutionizing cancer treatment through smart immune cell therapies.

Stay tuned for announcements about the exceptional talent joining our mission to develop the next generation of cell therapies.

Summer 2025

Advisory Board

NeXell Therapeutics is supported by a distinguished advisory board of experts in cell therapy, oncology, and biotechnology. Our advisors provide strategic guidance and deep domain expertise to accelerate our mission of developing smarter immune cell therapies.

Join Our Team

Help Us Transform Cancer Treatment

At NeXell Therapeutics, we're building a team of passionate, innovative thinkers dedicated to revolutionizing cancer treatment through smart immune cell therapies.

What We Value

Innovation: We push boundaries and think outside the box to solve complex challenges.
Collaboration: We believe the best solutions come from diverse perspectives working together.
Impact: We're driven by our mission to improve outcomes for cancer patients worldwide.
Excellence: We maintain the highest standards in our science and operations.

Current Opportunities

We're growing our team across multiple functions, including:

Cell Therapy Research
Synthetic Biology
Immunology
Process Development
Bioinformatics

Contact Us About Opportunities

Interested in Joining or Collaborating?

We're always looking for talented individuals and strategic partners to help advance our mission.

Get in Touch Learn About Our Technology